Joseph Ciccolini, PhD

home / authors / joseph-ciccolini-phd

Articles

Adjusting Dosing to Increase Efficacy of Cetuximab in Head and Neck Cancer

Adjusting Dosing to Increase Efficacy of Cetuximab in Head and Neck Cancer

April 10th 2017

Joseph Ciccolini, PhD, assistant professor in Pharmocokinetics, Aix-Marseille University, discusses how dosing adjustments may be used to increase the efficacy of agents, such as cetuximab (Erbitux) in patients with head and neck cancer.